期刊文献+

维药异常黑胆质成熟剂总黄酮对K562/ADR细胞的耐药逆转作用及mRNA表达的影响

Effect of Abnormal Savda Munzip on Reversal of Multidrug-resistance and Expression of mRNA of K562/ADR
下载PDF
导出
摘要 目的异常黑胆质成熟剂总黄酮ASMq对白血病K562/ADR多药耐药逆转作用机制研究及其对耐药株m RNA表达的影响。方法不同浓度的ASMq联合不同浓度的ADR作用于K562/ADR细胞株,用MTT法检测ASMq对K562/ADR的细胞毒活性及对耐药细胞株的抑制率,用RT-PCR方法分析对K562/ADR细胞ABCB-1及ABCC-1和BCL-2表达的影响。结果异常黑胆质成熟剂总黄酮ASMq对K562/ADR细胞株增值表现为抑制作用,对K562/ADR细胞耐药基因ABCC-1、ABCB-1及BCL-2同样表达抑制作用。结论异常黑胆质成熟剂总黄酮通过抑制ABCB-1、ABCC-1、BC-L2基因表达,发挥对K562/ADR细胞株耐药逆转的作用。 Objective The study on the mechanism of Abnormal Savda Munzip(ASMq)of drug resistance reversal of K562/ADR and its effect on the mRNA expression of drug-resistant strains.Methods Different concentrations of ASMq and different concentrations of ADR were given cutured K562/ADR cell lines,the cell toxicity of K562/ADR and inhibition rate of resistant cells were detemined by MTT method.The effects of the expression of ABCC-1,ABCB-1,BCL-2 in K562/ADR cells were analyzed by RT-PCR.Results ASMq has been found to down-regulater K562/ADR cell apoptosis related proteins expression:ABCC-1,ABCB-1.BCL-2 and restrain cell proliferation with dose-dependent Conclusion ASMq can reverse the drug resistance against K562/ADR cells,down-regulate the apoptosis related mRNA.
作者 赵莉 王学梅 王珍珍 严媚 ZHAO Li;WANG Xuemei;WANG ZHenzhen;YAN Mei(Department of Pediatrics, the First Afl'diated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, 830054, Chin)
出处 《新疆医学》 2018年第3期259-262,共4页 Xinjiang Medical Journal
基金 新疆维吾尔自治区自然科学基金项目(2014211C051)
关键词 异常黑胆质成熟剂总黄酮 K562/ADR细胞株 耐药逆转 RT-PCR ASMq k562/ADR Reversal of Multidrug-resistance RT-PCR
  • 相关文献

参考文献1

二级参考文献10

  • 1Trnkova Z, Bedrlikova R, Markova J, et al. Semiquantitative RT - PCR evaluation of the MDR1 gene expression in patients with acute myeloid leukemia [ J ]. Neoplasma, 2007,54(5 ) :383 - 390.
  • 2Plasschaert SL, de Bont ES, Boezen M, et al. Expression of multidrug resistance - associated proteins predicts prognosis in childhood and adult acute lymphoblastic leukemia [J]. Clin Cancer Res,2005,11 (24 Pt 1 ) :8661 -8668.
  • 3Plasschaert SL, Van Der Kolk DM, De Bont ES, et al. Breast cancer resistance protein (BCRP) in acute leukemia [J]. Leuk Lymphoma, 2004,45 (4) :649 - 654.
  • 4Swerts K, De Moerloose B, Dhooge C, et al. Prognostic significance of multidrug resistance - related proteins in childhood acute lymphoblastic leukemia [ J]. Eur J Cancer,2006,42(3) :295 - 309.
  • 5Van den Heuvel - Eibrink BM, Wiemer EA, Prins A, et al. Increased expression of breast cancer resistance protein (bcrp) in relapsed or refractory acute myeloid leukemia [ J]. Leukemia,2002,16( 5 ) :833 - 839.
  • 6Uggla B, Stahl E, Wagsater D, et al. BCRP mRNA expression v. clinical outcome in 40 adult AML patients[ J ]. Leuk Res,2005,29 ( 2 ) : 141 - 146.
  • 7Damiani D, Tiribelli M, Calistri E, et al. The prognostic value of Pglycoprotein(ABCB) and breast cancer resistance protein (ABCG2) in adults with de novo acute myeloid leukemia with normal karyotype [ J ]. Hematologica, 2006,91 (6) :825 - 828.
  • 8Benderra Z, Faussat AM, Sayada L, et al. Breast cancer resistance protein and P - glycoprotein in 149 adult acute myeloid leukemia [ J ]. Clin Cancer Res, 2004,10 (23) : 7896 - 7902.
  • 9Galimberti S, Guerrini F, Palumbo GA, et al. Evaluation of BCRP and MDR - 1 co - expression by quantitative molecular assessment in AML patients [ J]. Leuk Res,2004, 28(4) :367 - 372.
  • 10上海市白血病协作组.急性白血病患者P-gp、mdr1、MRP和TopoⅡ表达及其与预后关系的研究[J].中华血液学杂志,2001,22(2):90-93. 被引量:17

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部